Disposition of 25000 shares by Rivera Nayda of First Bancorp at 21.1936 subject to Rule 16b-3
| BIVRX Fund | USD 17.16 0.25 1.48% |
Slightly above 52% of Balter Invenomic's investors are presently thinking to get in. The analysis of overall sentiment of trading Balter Invenomic Fund mutual fund suggests that some investors are interested at this time. Balter Invenomic's investing sentiment can be driven by a variety of factors including economic data, Balter Invenomic's earnings reports, geopolitical events, and overall market trends.
Balter |
Filed transaction by First Bancorp Officer: Evp And Cro. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at investing.com
 |
Balter Invenomic Fundamental Analysis
We analyze Balter Invenomic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balter Invenomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balter Invenomic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Balter Invenomic is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Balter Invenomic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Balter Invenomic mutual fund to make a market-neutral strategy. Peer analysis of Balter Invenomic could also be used in its relative valuation, which is a method of valuing Balter Invenomic by comparing valuation metrics with similar companies.
Peers
Balter Invenomic Related Equities
| NEITX | Nebraska Municipal | 0.32 | ||||
| OKMUX | Oklahoma Municipal | 0.28 | ||||
| BXDYX | Barings Active | 0.22 | ||||
| PATFX | T Rowe | 0.18 | ||||
| MGGNX | Mirova Global | 0.11 | ||||
| MDMTX | Blrc Sgy | 0.09 | ||||
| TTRBX | Ambrus Core | 0.10 | ||||
| BSGAX | Sterling Capital | 0.12 |
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |